Thursday links: falling valuations
ReturnsHow major asset classes performed in September 2026. (capitalspectator.com)The Breakwave Tanker Shipping ETF ($BWET) has had quite a year. (etf.com)Energy stocks had a big Q3. (axios.com)A look at asset class returns YTD. (novelinvestor.com)RatesFour upsides from higher bond yields including, 'Higher bond yields may create more options for long-run asset allocators.' (ft.com)Contrarians are buying into the iShares 20+year Treasury bond ETF ($TLT). (marketwatch.com)Muni bonds look cheap relative to Treasuries. (bloomberg.com)FinanceBill Ackman's investment management company, Pershing Square ($PS), is getting the benefit of the doubt from investors. (barrons.com)The story behind Ethos Technologies ($LIFE) which you have likely heard advertised on podcasts. (hntrbrk.com)It's not your imagination, companies are talking a lot about AI. (apollo.com)A brief history of the Bloomberg Terminal. (spectrum.ieee.org)Weight loss drugsMore GLP use is for non-weight related issues. (wsj.co
Returns
- How major asset classes performed in September 2026. (capitalspectator.com)
- The Breakwave Tanker Shipping ETF ($BWET) has had quite a year. (etf.com)
- Energy stocks had a big Q3. (axios.com)
- A look at asset class returns YTD. (novelinvestor.com)
Rates
- Four upsides from higher bond yields including, 'Higher bond yields may create more options for long-run asset allocators.' (ft.com)
- Contrarians are buying into the iShares 20+year Treasury bond ETF ($TLT). (marketwatch.com)
- Muni bonds look cheap relative to Treasuries. (bloomberg.com)
Finance
- Bill Ackman's investment management company, Pershing Square ($PS), is getting the benefit of the doubt from investors. (barrons.com)
- The story behind Ethos Technologies ($LIFE) which you have likely heard advertised on podcasts. (hntrbrk.com)
- It's not your imagination, companies are talking a lot about AI. (apollo.com)
- A brief history of the Bloomberg Terminal. (spectrum.ieee.org)
Weight loss drugs
- More GLP use is for non-weight related issues. (wsj.com)
- GLP-1s are being marketed for a lot of things other than weight loss. (theatlantic.com)
- A new Eli Lilly ($LLY) combo drug shows greater efficacy than tirzepatide alone. (cnbc.com)
- Drug makers now want to target belly fat. (wsj.com)
Apple
- Everything is pointing toward an Apple ($AAPL) HomePod release. (spyglass.org)
- Using the Mac Studio for local AI. (wired.com)
Stay in touch
- Don't miss a thing! Sign up for our daily e-mail newsletter. (abnormalreturns.com)
- Work in wealth management? Sign up for our exclusive Talking Wealth newsletter. (talkingwealthpod.com)
Food
- The dreaded 'What's for dinner?' question. (wsj.com)
- Gourmet grocers sit between scratch cooking and delivery. (grubstreet.com)
- The best diner is the one you actually go to. (livealittle.substack.com)
- RIP, brunch. (wsj.com)
Economy
- Weekly initial jobless claims are at historic lows. (bonddad.blogspot.com)
- Consumer spending has diverged from consumer sentiment. (econbrowser.com)
- The wealth effect is real. (axios.com)
Earlier on Abnormal Returns
- Longform links: AI acceleration. (abnormalreturns.com)
- What you missed in our Wednesday linkfest. (abnormalreturns.com)
- Personal finance links: the purpose of money. (abnormalreturns.com)
Mixed media
Share
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0